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Abstract
Purpose Rising rates of obesity have been recently asso-
ciated to the novel concept of food addiction (FA). The
Yale Food Addiction Scale (YFAS) is the most widely used
measure for examining FA (1) and analysis of its reliability
and validity is expected to facilitate empirical research on
the construct. Here, we tested the psychometric properties
of a Portuguese version of the YFAS (P-YFAS), estab-
lishing its factor structure, reliability and construct validity.
Methods Data were obtained from 468 Portuguese indi-
viduals, 278 sampled from non-clinical populations, and
190 among obese candidates for weight-loss surgery. A
battery of self-report measures of eating behavior was
applied.
Results Confirmatory factor analysis verified a one-factor
structure with acceptable fit, with item analysis suggesting
the need to eliminate item 24 from the P-YFAS. Internal
consistency (KR-20 = .82) and test–retest stability were
adequate. Correlation analyses supported convergent and
divergent validity of the P-YFAS, particularly in the clin-
ical sample. Both FA symptom count and diagnosis,
according to the P-YFAS, adequately discriminated
between samples, with classification of FA met by 2.5 and
25.8% of the participants in the non-clinical and clinical
samples, respectively.
This article is part of the topical collection on Food addiction.
Electronic supplementary material The online version of this
article (doi:10.1007/s40519-016-0349-6) contains supplementary
material, which is available to authorized users.
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Conclusions These findings reinforce the use of P-YFAS
in non-clinical and clinical populations. Future directions
for extending YFAS validation are discussed.
Keywords Food addiction  Obesity  Reward 
Psychometrics
Introduction
Obesity is a serious public health problem across the world
and, despite increased efforts of prevention and treatment,
its prevalence has risen substantially [2], sustaining the
need for development of novel etiological hypotheses and
strategies for management of this condition [3]. While the
importance of exposure to calorie-rich environments is
relatively consensual, the factors explaining differential
susceptibility for obesity among individuals exposed to
such environments are controversial [4]. Factors similar to
those seen in substance dependence and addiction have
been proposed to underlie the individual risk of obesity, in
a process characterized by food cravings, loss of control
over consumption of calorie-dense foods, increased intake
over time, and unsuccessful efforts to eat less [5, 6]. Such
process of ‘‘food addiction’’ (FA) is thought to lead to
overeating, which in turn contributes to weight gain [7, 8].
Nevertheless, FA is only one among several etiological
factors underlying obesity, and it is neither ubiquitous
among obese patients, nor sufficient for the occurrence of
obesity [9].
Evidence for validity of the FA construct, both at a
behavioral and a neurobiological level, has been
progressively supported by research with humans and with
animal models [10]. Nevertheless, the concept remains
controversial, and it is clear that further research is war-
ranted to better define and understand the behavioral and
neurobiological profile of FA [11]. This growing area of
research has been supported by development of the Yale
Food Addiction Scale YFAS; [12], a self-report measure of
addiction-like eating behaviors, based on the diagnostic
criteria for substance dependence, as defined in the DSM-
IV-TR [13]. This instrument allows for an examination of
the psychological, behavioral, cognitive and physiological
indicators of addiction-like responses to food [14]. Even
considering recent changes in the criteria for substance use
disorders, proposed in the DSM-V, the overlap with pre-
vious criteria supports its continued use [15].
The YFAS is currently available in many languages
[12, 16–20], and most studies suggest that it is psycho-
metrically sound for the study of FA. Support for validity
of the YFAS has also emerged in a variety of relevant
populations, namely patients with eating disorders [19] or
who are overweight or obese [21], including those in
weight-loss surgery programs [22, 23]. According to a
recent meta-analysis, the mean prevalence of FA as
assessed by the YFAS was 11.1% in normal-weight indi-
viduals, while in patients with overweight/obesity, it
increased to 24.9%, and was even higher (57.6%) among
those with binge eating disorder (BED) and bulimia ner-
vosa [24]. However, there are also data that question the
relevance of FA in the context of obesity and weight-loss
treatment. In fact, while Burmeister et al. [1] confirmed
that elevated scores on the YFAS were related to less
success after 7 weeks of weight-loss treatment, other
studies have found only a trend [23] or no effect, at all, of
FA on weight loss [25]. Further research is, thus, necessary
to clarify the predictive validity of FA in the context of
weight-loss treatments, namely through use of the YFAS.
This study was aimed to validate the YFAS for use in
Portuguese-speaking adult populations.
Methods
Participants
This study was conducted using two separate samples. The
non-clinical sample consisted of 278 participants, recruited
from three educational institutions using non-probabilistic
sampling. The clinical sample, on the other hand, was
composed of 190 participants with obesity, recruited using
sequential sampling at weight-loss surgery clinics in three
Portuguese hospitals (Centro Hospitalar de Sa˜o Joa˜o,
Hospital do Espı´rito Santo, and Hospital Sa˜o Bernardo-
Centro Hospitalar de Setu´bal). Participants younger than
8 Instituto de Sau´de Ambiental, Faculdade de Medicina da
Universidade de Lisboa, Avenida Prof. Egas Moniz,
1649-028 Lisbon, Portugal
9 Department of Psychiatry, Centro Hospitalar de S. Joa˜o,
Alameda Prof. Hernaˆni Monteiro, 4200-319, Porto, Portugal
10 Faculdade de Medicina da Universidade do Porto, Alameda
Prof. Hernaˆni Monteiro, 4200-319, Porto, Portugal
11 Department of Psychiatry, Centro Hospitalar de Lisboa
Norte, Avenida Prof. Egas Moniz, 1649-035 Lisbon, Portugal
12 Department of Psychiatry, Faculdade de Medicina da
Universidade de Lisboa, Avenida Prof. Egas Moniz,
1649-028 Lisbon, Portugal
13 Department of Psychiatry and Mental Health, Centro
Hospitalar de Lisboa Ocidental, Rua da Junqueira,
1349-019 Lisbon, Portugal
14 NOVA School of Medicine | Faculdade de Cieˆncias Me´dicas,
Universidade Nova de Lisboa, Campo dos Ma´rtires da Pa´tria,
1169-056 Lisbon, Portugal
15 Champalimaud Research, Champalimaud Centre for the
Unknown, Avenida de Brası´lia, Doca de Pedrouc¸os,
1400-038 Lisbon, Portugal
260 Eat Weight Disord (2017) 22:259–267
123
18 years of age were not eligible. Those with self-reported
active neurological, psychiatric, gastrointestinal, hepatic or
pancreatic diseases, illicit substance use or alcohol abuse
and dependence, prior major gastrointestinal surgery, intra-
gastric balloon or history of food allergies, as well as those
who were pregnant, breastfeeding, illiterate or did not
understand instructions for study, were excluded.
Material
Yale Food Addiction Scale (YFAS). The YFAS [12] con-
sists of 25 self-report items measuring addiction-like eating
behaviors of high fat/sugar foods, occurring over the prior
year. The seven symptoms of substance dependence, as
outlined in the DSM-IV-TR (American Psychiatric Asso-
ciation, 2000), were revised to apply to eating behavior:
consumption in greater quantity and for longer than
intended; desire or unsuccessful effort to cut down or quit
consumption; large amount of time and effort to obtain,
consume, and recover from consumption; important social,
occupational, or recreational activities given up or reduced;
continued behavior despite knowledge of adverse physical
and psychological consequences; tolerance; and with-
drawal. In addition to 20 items distributed across the seven
criteria (symptoms), 2 items are designed to assess clini-
cally significant impairment, and 3 items serve as primers
for other questions. Each symptom is satisfied when one or
more of the respective items are endorsed. The YFAS
provides two scoring options, a continuous version of the
scale (YFAS symptom count) that indicates the number of
dependence symptoms that have been met (scores range
from 0 to 7), and a dichotomous version that provides a
diagnosis of FA (i.e., FA status yes/no) when the respon-
dent presents at least three symptoms and reports clinically
significant impairment and/or distress.
Other self-report instruments. The Portuguese Power of
Food Scale P-PFS [26] is a Portuguese version of the PFS
[27], a 15-item questionnaire that assesses psychological
impact of an environment with high availability of palat-
able foods. It rates three dimensions of proximity to food:
food available but not physically present, food physically
present but not yet tasted, and food tasted but not yet
consumed. For this study, Cronbach’s alpha (a) of the
P-PFS was .88 for the non-clinical sample and .93 for the
clinical sample. The Portuguese Dutch Eating Behavior
Questionnaire P-DEBQ [28] is a Portuguese version of the
DEBQ [29], a 33-item questionnaire assessing different
aspects of eating behaviors, distributed in three subscales:
restrained eating, emotional eating and external eating
(non-clinical sample—a = .93; clinical sample—a = .90).
The Portuguese Eating Disorder Inventory P-EDI [30] is a
Portuguese version of the EDI [31], a 64-item measure
designed to assess psychological and behavioral traits
associated with eating disorders, across eight subscales:
drive for thinness, bulimia, body dissatisfaction, ineffec-
tiveness, perfectionism, interpersonal distrust, interocep-
tive awareness and maturity fears (non-clinical sample—
a = .88). The Portuguese Binge Eating Scale P-BES [32]
is a Portuguese version of the BES [33], a 16-item scale to
assess severity of binge eating using behavioral, cognitive
and affective symptoms (non-clinical sample—a = .89).
The Newest Vital Sign (NVS) [34] is a screening test
designed to assess health literacy. A Portuguese version (P-
NVS) is currently being developed [35] (non-clinical
sample—a = .78; clinical sample—a = .89).
Structured Clinical Interview for DSM-IV Axis I
Disorders (SCID-I). The SCID-I [36], a semi-structured
clinical interview for diagnosis of psychiatric disorders
according to DSM-IV Axis I, translated and adapted to
Portuguese by Tavares [37], was used to assess lifetime
and current BED diagnosis in the clinical sample. Dif-
ferent raters applied this interview in the North and South
of Portugal, allowing for assessment of the association
between rater and SCID/BED diagnosis. The Chi-squared
test for independence (with Yates’ continuity correction)
indicated that there was no significant association
between these variables (v2 (1) = .81, p = .276,
u = .10).
Body mass index (BMI). The BMI (kg/m2) of the non-
clinical participants was calculated according to self-re-
ported height and weight values provided by participants.
In the clinical sample, height and weight were obtained by
direct measurement with a SECA digital scale and
stadiometer.
Procedures
Permission for translation and validation of a Portuguese
version of the YFAS was granted by the original authors
(Ashley Gearhardt). The translation process was based on
the back-translation technique [38]. The study protocol was
approved by Ethics Committees at the Champalimaud
Foundation, Faculdade de Medicina da Universidade de
Lisboa, Universidade de E´vora, Centro Hospitalar de Sa˜o
Joa˜o and Hospital Sa˜o Bernardo-Centro Hospitalar de
Setu´bal. Written informed consent was obtained from all
subjects.
A pilot study was carried out with a preliminary version
of the Portuguese YFAS (P-YFAS), administered to 7
individuals with obesity and 10 normal-weight individuals,
of both genders. Pilot participants were interviewed to
assess their reactions to item difficulty, wording and
meaning, as well as to the instructions for administration,
leading to minor adaptations on wording of several items
and a final version of the P-YFAS.
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In the non-clinical and clinical samples, self-adminis-
tered questionnaires were applied using a paper-and-pencil
format, completed after socio-demographic information
(gender, age, and education) and anthropometric data were
collected. The assessment protocol differed slightly
between samples: YFAS, PFS, DEBQ and NVS were
applied to both samples, the EDI and BES only to the non-
clinical sample, and the SCID-I (BED diagnosis) only to
the clinical sample. To assess test–retest reliability, the
YFAS was re-administered 4 weeks later in a subgroup of
104 participants of the non-clinical sample. This interval
was chosen to allow for comparisons with existing data
[18]. Temporal stability of the scale was also verified in 30
participants of the clinical sample, with time intervals of up
to 8 months, which are closer to customary clinical
reassessment time points.
Data analysis
Data analysis was focused on exploring the psychometric
properties of the P-YFAS. Based on the one-factor model
found in previous studies e.g., [12, 17, 20, 22], a confir-
matory factor analysis for dichotomous data (not including
the primer items) was conducted on Mplus version 6.0,
using a mean- and variance-adjusted weighted least square
(WLSMV) estimator with a polychoric correlation matrix.
To assess model fit, several criteria were considered: root
mean square error of approximation (RMSEA)\.06 [39],
comparative fit index (CFI)[.90 [40], weighted root mean
square residual (WRMR)\1.0 [41], non-significant Chi-
squared (v2) test (p\ .05) [42], and normed Chi-squared
(v2/df)\3.0 [43]. Internal reliability was assessed using the
Kuder–Richardson’s alpha (KR-20) and, in the non-clinical
sample, test–retest reliability was estimated using the two-
way mixed, single-measure intraclass correlation coeffi-
cient (ICC). To test temporal stability of P-YFAS symptom
count in the clinical sample, two subsamples were con-
sidered according to test–retest time intervals, namely short
(6–8 weeks) and long (3–8 months) intervals. Paired-
samples t tests were conducted to analyze whether there
were differences in the means of these subsamples at the
two time points.
Distributions of continuous measures (total scores and
subscales) used to analyze YFAS validity were examined
for normality, independently in clinical and non-clinical
samples, and found to be normally distributed, as per
analysis of kurtosis, skewness and comparison of mean and
median. Association between P-YFAS diagnosis and age,
education (years of schooling) and BMI was examined
using two-tailed Student’s t tests (with Cohen’s d to pro-
vide a measure of effect size), and association with gender
using independence v2 tests (with Yates’ continuity cor-
rection). Convergent validity was assessed using Pearson
correlation coefficients (r) between P-YFAS symptom
count and other instruments measuring eating behaviors,
specifically instruments most linked to binge eating and/or
reward-related eating. The P-PFS and selected P-DEBQ
subscales (emotional eating and external eating) were used
in both samples, while the P-BES total score and selected
P-EDI subscales (bulimia, body dissatisfaction, and drive
for thinness, representing the best screen for BED
according to the recent literature [44]), were used in the
non-clinical sample. Divergent validity was assessed using
Pearson correlations between P-YFAS symptom count and
related but distinct constructs, following the same proce-
dure adopted in previous psychometric studies on the
YFAS. Here, we considered the dietary restraint (DEBQ
restrained eating subscale) and health literacy (NVS) con-
structs. In the non-clinical sample, three P-EDI subscales
(maturity fears, perfectionism, and interpersonal distrust,
chosen based on their low screening properties for BED
[44]) were additionally used to test divergent validity. To
assess discriminative validity, we performed a one-way
analysis of covariance (ANCOVA) to compare the mean
scores of the P-YFAS symptom count in clinical and non-
clinical samples, while adjusting for age and education.
With the exception noted above, data analyses were
performed using SPSS version 22.0. All analyses were two-
tailed, with significance considered at p\ .05.
Results
In the non-clinical and clinical samples, participation rate
was 97.8 and 88.8%, respectively. See Table 1 for a
summary of socio-demographic and clinical characteristics
for participants of both samples.
P-YFAS factor structure and reliability
Confirmatory factor analysis with P-YFAS dichotomous
items achieved satisfactory goodness of fit for a one-di-
mensional solution (data not shown). Internal reliability
was good (KR-20 = .80) and, with one exception, all items
presented a significant coefficient. Item #24 presented a
non-significant coefficient and a very low item-total cor-
relation (.06), prompting its exclusion and repetition of
analyses (see supplementary material, Table S1). After
excluding item #24, fit statistics improved [v2 (189) = 456,
p\ .001, v2/df = 2.41; RMSEA = .06, 90% CI .05/.06, p
(RMSEA\ .05) = .06; CFI = .90; WRMR = 1.41] with
satisfactory fit achieved for all indices with the exception
of the v2 test. The latter was significant possibly due to the
fact that the v2 statistic is sensitive to sample size. The KR-
20 internal reliability coefficient was .82 and all items
loaded significantly on the common factor (p\ .001), with
262 Eat Weight Disord (2017) 22:259–267
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item-total correlations between .20 and .60. Five items (#4,
#11, #21, #22, and #25) had low item-total correlations (.20
to .30), but KR-20 did not decrease when these items were
deleted (see supplementary material, Table S1). Thus, a
one-factor model without item #24 was the factorial
structure proposed for the P-YFAS. To verify differences
between the P-YFAS and the original YFAS, all the fol-
lowing analyses were performed with both versions. Since
differences between the two versions were not significant,
only the results regarding the final 21-item P-YFAS are
presented from here on.
Test–retest reliability in the non-clinical sample was
adequate (ICC = .64, 95% CI .51–.74). In the clinical
sample, there were no significant differences in the YFAS
mean scores for test and retest, after both short
(t(12) = -0.39, p = .701, g
2 = .01) and long (t(14) = 0.61,
p = .551, g2 = .03) reassessment intervals.
FA diagnosis: prevalence and associated socio-
demographic and clinical features
FA diagnosis was ascertained using the P-YFAS in all
subjects from the non-clinical sample, and in all but 12
subjects from the clinical sample. For those 12 subjects,
this was not possible due to missing data. FA was, thus,
diagnosed in 2.5% (n = 7) of the non-clinical sample and
25.8% (n = 46) of the clinical sample. Similar FA rates
were found using the 22-item version of the P-YFAS (2.9
and 25.8%, respectively). Endorsement rates of each
symptom assessed by the P-YFAS are available as sup-
plementary material (Table S2). Associations between FA
diagnosis and gender were not significant in the non-clin-
ical (v2(1, n = 278) = .02, p = .898, u = -.03) or the
clinical sample (v2(1, n = 178) = .42, p = .515, u = -.07).
FA diagnosis was also not associated with years of
schooling and BMI (Table 2). Differences in FA diagnosis
were found only according to age in the non-clinical
sample, where individuals with FA diagnosis were found to
be younger (M = 20.29, SD = 1.98) than the remaining
sample (M = 23.13, SD = 6.31; tWelch(9.8) = 3.37,
p = .007, d = .59). Given the small number of individuals
with FA diagnosis in the non-clinical sample, this finding
should be considered with caution.
Convergent, divergent, and discriminative validity
Table 3 shows correlations between P-YFAS symptom
count and clinical measures selected to test convergent and
divergent validity. When compared with other measures
relevant to eating behavior, the P-YFAS achieved adequate
convergent validity in the non-clinical sample
(.216\ r\ .487, p\ .001), and good convergent validity
(.412\ r\ .727, p\ .001) in the clinical sample.
Regarding divergent validity, correlations were non-sig-
nificant, with exception of the DEBQ restrained eating
subscale, which correlated slightly, but significantly, with
P-YFAS symptom count in both samples.
Discriminative validity of the scale was supported by
finding of a significant difference between the two samples
on P-YFAS symptom count scores (non-clinical sample:
M = 1.55, SD = 1.31; clinical sample: M = 2.81,
SD = 1.87), even after adjusting for age and education
(F(1, 452) = 25.25, p\ .001, g2p = .05; ANCOVA). Among
the clinical sample, the proportion of individuals with an
FA diagnosis (25.8%) was also significantly higher than
what was found for the non-clinical sample (2.5%;
v2(1, n = 456) = 55.23, p\ .001, u = .36; v
2 test).
Discussion
This study describes the translation of the YFAS [12] into
Portuguese (P-YFAS), with assessment of its psychometric
properties, in terms of validity (construct, convergent,
divergent, and discriminative) and reliability (internal
consistency and test–retest), measured in two adult samples
(non-clinical and clinical). We confirmed the previously
proposed one-factor structure of the YFAS after excluding
item #24 (unsuccessful effort to cut down), given its non-
significant coefficient and very low item-total correlation.
Exclusion of item #24 has been reported in other versions
of the scale [16–20, 22], with suggestions towards its
removal from the questionnaire [16, 17, 20]. Both in our
study and those mentioned above, item # 24, along with
others that compose the criterion for ‘‘persistent desire or
unsuccessful attempts to quit’’ (items #4, #22, #25), allow
only for a slight differentiation between food-addicted and
Table 1 Socio-demographic
and clinical information of the
non-clinical and the clinical
samples
Non-clinical (n = 278) Clinical (n = 190) t d
Age M (SD) 23.06 (6.43) 43.21 (10.39) -23.80*** -2.33
Education M (SD) 11.31 (2.13) 9.72 (4.26) 4.76*** .47
BMI M (SD) 22.65 (3.35) 43.24 (5.80) -44.04*** -4.35
Gender (% women) 66.5% 87.4% v2 = 25.00***
BMI body mass index, Education years of formal education
*** p\ .001
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non-addicted individuals (see Table S2). We believe that
the low discriminative power of these items could result
from the prevalence of dieting in the general population
[45]. Important next steps in FA research include further
refinement of the YFAS, with selection of the more specific
items associated to FA.
The P-YFAS exhibited good internal reliability, and
test–retest analysis also supported stability of the scale.
As yet, only two studies have investigated the stability of
the YFAS across time [18, 46]. Both were conducted with
non-clinical populations and achieved an ICC slightly
higher than what was found here, also for the non-clinical
population (*.70). Here, we also report, to our knowl-
edge for the first time, preliminary data for temporal
stability of the YFAS in a clinical population. In this
population, even though we tested a smaller group of
individuals (n = 30) over longer time intervals (up to
8 months), the P-YFAS was found to be relatively
stable at both shorter (6–8 weeks) and longer
(3–8 months) intervals.
Table 2 Differences in age,
education, and BMI according
to P-YFAS diagnostic threshold
No food addiction
M (SD)
Food addiction
M (SD)
t p* Cohen’s d
Non-clinical sample (n = 278)
Age 23.13 (6.31) 20.29 (1.98) 3.37 .007 .59
Education 11.32 (2.15) 10.57 (1.13) 1.68 .136 .44
BMI 22.61 (3.35) 24.11 (3.24) -1.17 .245 -.45
Clinical sample (n = 178)
Age 42.49 (10.04) 44.91 (11.26) -1.36 .174 -.23
Education 10.07 (4.07) 9.50 (4.81) .72 .476 .13
BMI 43.10 (5.47) 44.33 (6.86) -1.22 .224 -.20
BMI body mass index; Education years of formal education
* Significant p values are in bold
Table 3 Convergent and
divergent validity
P-YFAS symptom count
Non-clinical sample Clinical sample
Convergent validity
P-PFS—total score .413*** .727***
P-PFS—food available .449*** .701***
P-PFS—food present .216*** .610***
P-PFS—food tasted .310*** .615***
P-DEBQ—external eating .449*** .608***
P-DEBQ—emotional eating .346*** .624***
P-EDI—bulimia .317*** –
P-EDI—body dissatisfaction .319*** –
P-EDI—drive for thinness .303*** –
Binge eatinga .487*** .412***
Divergent validity
P-NVS -.030 -.071
P-DEBQ—restrained eating .236** -.165*
P-EDI—maturity fears .101 –
P-EDI—perfectionism .139 –
P-EDI—interpersonal distrust .128 –
– indicates that the measure was only available for non-clinical sample
P-YFAS Portuguese version of the Yale Food Addiction Scale, P-PFS Portuguese version of the Power of
Food Scale, P-DEQB Portuguese version of the Dutch Eating Behavior Questionnaire, P-EDI Portuguese
version of the Eating Disorder Inventory, P-NVS Portuguese version of the Newest Vital Sign
* p\ .05; ** p\ .01; *** p\ .001
a Binge eating was assessed by the Binge Eating Scale (P-BES), in non-clinical sample, and the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I), in clinical sample
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Using the P-YFAS, we found an FA prevalence of 2.5%
in the non-clinical sample and 25.8% in the clinical sam-
ple. To date, three studies analyzed the prevalence of FA in
weight-loss surgery candidates and reported considerably
higher rates: 31.8% [47], 41.7% [22], and 53.7% [23].
Comparing the samples of these studies, we did not find
striking differences regarding age, and there are insufficient
data to allow for comparisons of BMI. The FA rate in our
non-clinical sample was also lower than in previous studies
using student [16, 18] and population-based samples [17],
with prevalence rates around 9%. Only one study [48]
found a rate similar to ours (1.6%), but in participants
classified as underweight or normal-weight. In our sample,
these BMI classes represented 80.2% of the participants,
which may have had some impact in FA assessment.
However, given the limited evidence for differences in FA
prevalence according to weight or age categories [9], this
hypothesis should be considered cautiously, and the impact
of these and other clinical and socio-demographic variables
on the expression of FA symptoms should be further
explored. In interpretation of our findings, we are more
inclined to argue that the FA assessment can be sensitive to
cultural eating habits and food preferences. Culture can
affect attitudes towards food, differences in accepted por-
tion sizes, and personal feelings of embarrassment and
distress towards overeating [49]. It is possible that in
Portugal, a country with rich gastronomic tradition, people
view larger food portions as more acceptable than in other
countries. The question regarding cultural differences in
FA symptomatology is, thus, in our view, essential to
extend validation of the YFAS.
The P-YFAS symptom count score was shown to have
adequate convergent and divergent validity, with moderate
to high correlations between the P-YFAS score and mea-
sures of eating pathology. Contrary to our expectation, in
divergent validity analysis, we observed small yet signifi-
cant correlations between P-YFAS and P-DEBQ restrained
eating subscale scores. In fact, these two constructs,
apparently with opposite expressions (restrictive eating vs.
overeating), can be related to the extent that intense dieting
may result in persistent hunger and limit cognitive control,
making dieters susceptible to disinhibited eating. Dietary
restraint may, thus, represent an ‘‘intent to diet’’ rather than
caloric restriction per se [29]. Discriminative validity of the
P-YFAS was also supported given that, after adjusting for
age and education, the symptom count score was able to
differentiate between clinical and non-clinical samples, and
the P-YFAS diagnostic also differed significantly accord-
ing to sample group (clinical vs. non-clinical).
The results of our study must be interpreted in the
context of the study design. The main findings are based on
self-reported measures, implying risks regarding accuracy
[50]. Generalizability of our findings is also a concern, with
the clinical sample predominantly female and comprising a
specific group of patients with obesity: candidates for
weight-loss surgery. Confirmation of the psychometric
properties of the P-YFAS should, thus, be performed with
larger samples of individuals, including broader profiles of
patients with obesity. Specifically with regards to short-
and mid-term stability of the scale, future research should
extend current findings in both samples, since the mid-term
stability in non-clinical samples has been analyzed only
once [46], and the data we provide regarding stability in
clinical samples are preliminary due to the small number of
participants that were re-assessed. Finally, the unbalance in
sample sizes in this study, resulting from the smaller size of
our clinical sample, limited the testing of whether the same
P-YFAS configuration holds across groups. In future
studies, it would be pertinent to test measurement invari-
ance between groups, namely between clinical and non-
clinical samples.
Conclusions
Here, we have translated and adapted the Portuguese
version of the YFAS in non-clinical and clinical samples,
and found it to have adequate psychometric properties.
Nevertheless, our data raised questions related to con-
ceptual definition of the symptom ‘‘unsuccessful effort to
cut down’’, which seems to be a broad and unspecific
symptom. Furthermore, the lower percentage of FA
diagnosis found in our samples suggests that the YFAS is
sensitive to cultural food habits and preferences. Future
directions for extending YFAS validation should include
the clarification of the impairments specific to FA con-
dition and their relationship with clinical and socio-de-
mographic variables, distinctively in clinical and non-
clinical samples.
Acknowledgements The authors would like to thank Ashley Gear-
hardt (Department of Psychology, University of Michigan) for pro-
viding access to the Yale Food Addiction Scale and contributing to
the adaptation process. We would also like to thank Centro Hospitalar
de S. Joa˜o, Hospital Sa˜o Bernardo, Faculdade de Cieˆncias da Nutric¸a˜o
e Alimentac¸a˜o da Universidade do Porto, Hospital Espı´rito Santo de
E´vora, Instituto do Emprego e Formac¸a˜o Profissional, Universidade
Atlaˆntica and Universidade de E´vora, in particular Ana Andre´, Andre´
Ferreira, Andreia Santos, Anto´nio-Roma-Torres, Armando Rai-
mundo, Carlos Trindade, Cecı´lia Silva, Cristina Pontes, Manuel
Carvalho, Margarida Pegacho, Mo´nica Silva, Rita Fernandes and Sara
Pacheco, for assistance with recruitment of participants.
Compliance with ethical standards
Funding This work was supported by Fundac¸a˜o para a Cieˆncia e
Tecnologia through a Junior Research and Career Development
Award from the Harvard Medical Portugal Program (HMSP/ICJ/
0020/2011) to AJO-M and CPUP (UID/PSI/00050/2013) to ST, and a
Grant from the BIAL Foundation (176/10) to AJO-M.
Eat Weight Disord (2017) 22:259–267 265
123
Conflict of interest On behalf of all authors, the corresponding
author states that there is no conflict of interest.
Ethical approval All procedures performed in this study were in
accordance with the ethical standards of the institutional and/or
national research committee and with the 1964 Helsinki declaration
and its later amendments or comparable ethical standards.
Informed consent Informed consent was obtained from all individ-
ual participants included in the study.
References
1. Burmeister JM, Hinman N, Koball A, Hoffmann DA, Carels RA
(2013) Food addiction in adults seeking weight loss treatment.
Implications for psychosocial health and weight loss. Appetite
60:103–110. doi:10.1016/j.appet.2012.09.013
2. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono
C et al (2014) Global, regional, and national prevalence of
overweight and obesity in children and adults during 1980–2013:
a systematic analysis for the Global Burden of Disease Study
2013. Lancet 384:766–781. doi:10.1016/S0140-6736(14)60460-8
3. Oliveira-Maia J, Roberts CD, Simon SA, Nicolelis MAL (2011)
Gustatory and reward brain circuits in the control of food intake.
Adv Tech Stand Neurosurg 36:31–59. doi:10.1007/978-3-7091-
0179-7_3
4. Schulte E, Joyner M, Potenza M, Grilo C, Gearhardt A (2015)
Current considerations regarding food addiction. Curr Psychiatry
Rep 17:1–8. doi:10.1007/s11920-015-0563-3
5. Fortuna JL (2012) The obesity epidemic and food addiction:
clinical similarities to drug dependence. J Psychoact Drugs
44:56–63. doi:10.1080/02791072.2012.662092
6. Gearhardt AN, Corbin WR, Brownell KD (2009) Food addiction:
an examination of the diagnostic criteria for dependence. J Addict
Med 3:1–7. doi:10.1097/ADM.0b013e318193c993
7. Gearhardt AN, White MA, Potenza MN (2011) Binge eating
disorder and food addiction. Curr Drug Abus Rev 4:201–207
8. Davis C, Carter JC (2009) Compulsive overeating as an addiction
disorder. A review of theory and evidence. Appetite 53:1–8.
doi:10.1016/j.appet.2009.05.018
9. Meule A (2011) How prevalent is ‘food addiction’? Front Psy-
chiatry 2:1–4. doi:10.3389/fpsyt.2011.00061
10. Davis C (2013) From passive overeating to ‘‘Food Addiction’’: a
spectrum of compulsion and severity. ISRN Obes 2013:1–20.
doi:10.1155/2013/435027
11. Ziauddeen H, Fletcher PC (2013) Is food addiction a valid and
useful concept? Obes Rev 14:19–28. doi:10.1111/j.1467-789X.
2012.01046.x
12. Gearhardt AN, Corbin WR, Brownell KD (2009) Preliminary
validation of the Yale Food Addiction Scale. Appetite
52:430–436. doi:10.1016/j.appet.2008.12.003
13. American Psychiatric Association (2000) Diagnostic and statis-
tical manual of mental disorders, 4th edn. American Psychiatric
Press, Washington
14. Meule A, Gearhardt AN (2014) Five years of the Yale Food
Addiction Scale: Taking stock and moving forward. Curr Addict
Rep 1:193–205. doi:10.1007/s40429-014-0021-z
15. Meule A, Gearhardt AN (2014) Food Addiction in the Light of
DSM-5. Nutrients 6:3653–3671. doi:10.3390/nu6093653
16. Meule A, Vo¨gele C, Ku¨bler A (2012) German translation and
validation of the Yale Food Addiction Scale. Diagnostica
58:115–126. doi:10.1026/0012-1924/a000047
17. Brunault P, Ballon N, Gaillard P, Re´veille`re C, Courtois R (2014)
Validation of the French version of the Yale Food Addiction
Scale: an examination of its factor structure, reliability, and
construct validity in a nonclinical sample. Can J Psychiatry
59:276–284
18. Chen G, Tang Z, Guo G, Liu X, Xiao S (2015) The Chinese
version of the Yale Food Addiction Scale: an examination of its
validation in a sample of female adolescents. Eat Behav
18:97–102. doi:10.1016/j.eatbeh.2015.05.002
19. Granero R, Hilker I, Agu¨era Z, Jime´nez-Murcia S, Sauchelli S,
Islam MA et al (2014) Food Addiction in a Spanish Sample of
Eating Disorders: DSM-5 Diagnostic Subtype Differentiation and
Validation Data. Eur Eat Disord Rev 22:389–396. doi:10.1002/
erv.2311
20. Innamorati M, Imperatori C, Manzoni G, Lamis D, Castelnuovo
G, Tamburello A et al (2015) Psychometric properties of the
Italian Yale Food Addiction Scale in overweight and obese
patients. Eat Weight Disord 20:119–127. doi:10.1007/s40519-
014-0142-3
21. Davis C, Curtis C, Levitan RD, Carter JC, Kaplan AS, Kennedy
JL (2011) Evidence that food addiction is a valid phenotype of
obesity. Appetite 57:711–717. doi:10.1016/j.appet.2011.08.017
22. Meule A, Heckel D, Ku¨bler A (2012) Factor structure and item
analysis of the Yale Food Addiction Scale in obese candidates for
bariatric surgery. Eur Eat Disord Rev 20:419–422. doi:10.1002/
erv.2189
23. Clark SM, Saules KK (2013) Validation of the Yale Food
Addiction Scale among a weight-loss surgery population. Eat
Behav 14:216–219. doi:10.1016/j.eatbeh.2013.01.002
24. Pursey KM, Stanwell P, Gearhardt AN, Collins CE, Burrows TL
(2014) The prevalence of food addiction as assessed by the Yale
Food Addiction Scale: a systematic review. Nutrients
6:4552–4590. doi:10.3390/nu6104552
25. LentMR,EichenDM,GoldbacherE,WaddenTA,FosterGD(2014)
Relationship of food addiction to weight loss and attrition during
obesity treatment. Obesity 22:52–55. doi:10.1002/oby.20512
26. Ribeiro G, Santos O, Camacho M, Torres S, Mucha-Vieira F,
Sampaio D et al (2015) Translation, cultural adaptation and
validation of the power of food scale for use by adult populations
in Portugal. Acta Med Port 28:575–582
27. Lowe MR, Butryn ML, Didie ER, Annunziato RA, Thomas JG,
Crerand CE et al (2009) The Power of Food Scale. A new
measure of the psychological influence of the food environment.
Appetite 53:114–118. doi:10.1016/j.appet.2009.05.016
28. Viana V, Sinde S (2003) Estilo Alimentar: Adaptac¸a˜o e validac¸a˜o
do Questiona´rio Holandeˆs do Comportamento Alimentar. Psic
Teor Inve Prat 1:59–71
29. Van Strien T, Frijters JER, Bergers G, Defares PB (1986) The
Dutch Eating Behavior Questionnaire (DEBQ) for assessment of
restrained, emotional, and external eating behavior. Int J Eat
Disord 5:295–315
30. Machado PP, Gonc¸alves S, Martins C, Soares IC (2001) The
Portuguese version of the Eating Disorders Inventory: Evaluation
of its psychometric properties. Eur Eat Disord Rev 9:43–52.
doi:10.1111/papt.12048
31. Garner DM, Olmsted MP, Polivy J (1983) Development and
validation of a multidimensional Eating Disorder Inventory for
anorexia nervosa and bulimia. Int J Eat Disord 2:15–34
32. Tapadinhas AR, Pais-Ribeiro J (2012) Validac¸a˜o da escala de
ingesta˜o compulsiva (BES). Um estudo com uma amostra de
obesos portugueses. Atas do 98 Congresso Nacional de Psicologia
da Sau´de. Lisboa: Placebo Editora. pp 1330–35
33. Gormally J, Black S, Daston S, Rardin D (1982) The assessment
of binge eating severity among obese persons. Addict Behav
7:47–55. doi:10.1016/0306-4603(82)90024-7
266 Eat Weight Disord (2017) 22:259–267
123
34. Weiss BD, Mays MZ, Martz W, Castro KM, DeWalt DA,
Pignone MP et al (2005) Quick assessment of literacy in primary
care: the newest vital sign. Ann Fam Med 3:514–522. doi:10.
1370/afm.405
35. Santos O, Oliveira A, Carvalho C, Lunet N, Azevedo A, Paiva D
et al (2012) Self-administration of the Newest Vital Sign in
Portuguese young adults: study of its internal reliability. Int J
Behav Med 19:S189
36. Spitzer RL, Williams JBW, Gibbon M, First MB (1990) Struc-
tured Clinican Interview for DSM-III-R (SCID). American Psy-
chiatric Press, Washington
37. Tavares M (1996) Entrevista clı´nica estruturada para o DSM-IV:
Transtornos do eixo I-edic¸a˜o para pacientes (SCID-I/P 2.0).
Instituto de Psicologia, Universidade de Brası´lia
38. Gudmundsson E (2009) Guidelines for translating and adapting
psychological instruments. Nord Psychol 61:29–45. doi:10.1027/
1901-2276.61.2.29
39. Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in
covariance structure analysis: Conventional criteria versus new
alternatives. Struct Equ Model 6:1–55. doi:10.1080/
10705519909540118
40. Byrne BM (2010) Structural equation modelling with AMOS:
Basic concepts, applications, and programming, 2nd edn. Rout-
ledge, New York
41. Yu CY (2002) Evaluating cutoff criteria of model fit indices for
latent variable models with binary and continuous outcomes.
University of California, Los Angeles
42. Barrett P (2007) Structural equation modelling: Adjudging model
fit. Pers Individ Differ 42:815–824. doi:10.1016/j.paid.2006.09.
018
43. Kline RB (2005) Principles and practice of structural equation
modeling, 2nd edn. Guilford Press, New York
44. Mustelin L, Ka¨rkka¨inen U, Kaprio J, Keski-Rahkonen A (2016)
The Eating Disorder Inventory in the screening for DSM-5 binge
eating disorder. Eat Behav 22:145–148. doi:10.1016/j.eatbeh.
2016.06.011
45. de Ridder D, Adriaanse M, Evers C, Verhoeven A (2014) Who
diets? Most people and especially when they worry about food.
Appetite 80:103–108. doi:10.1016/j.appet.2014.05.011
46. Pursey KM, Collins CE, Stanwell P, Burrows TL (2016) The
stability of ‘food addiction’ as assessed by the Yale Food
Addiction Scale in a non-clinical population over 18-months.
Appetite 96:533–538. doi:10.1016/j.appet.2015.10.015
47. Pepino MY, Stein RI, Eagon JC, Klein S (2014) Bariatric sur-
gery-induced weight loss causes remission of food addiction in
extreme obesity. Obesity 22:1792–1798. doi:10.1002/oby.20797
48. Pedram P, Wadden D, Amini P, Gulliver W, Randell E, Cahill F
et al (2013) Food addiction: its prevalence and significant asso-
ciation with obesity in the general population. PLoS One
8:e74832. doi:10.1371/journal.pone.0074832
49. Bennett S, Dodge T (2007) Ethnic-racial differences in feelings
of embarrassment associated with binge eating and fear of losing
control. Int J Eat Disord 40:454–459. doi:10.1002/eat.20374
50. Vitousek KB, Daly J, Heiser C (1991) Reconstructing the internal
world of the eating-disordered individual: Overcoming distortion
in self-report. Int J Eat Disord 10:647–666. doi:10.1002/1098-
108X(199111)10:6\647:AID-EAT2260100604[3.0.CO;2-T
Eat Weight Disord (2017) 22:259–267 267
123
